LACTIGA Trademark

Trademark Overview

On Thursday, September 19, 2019, a trademark application was filed for LACTIGA with the United States Patent and Trademark Office. The USPTO has given the LACTIGA trademark a serial number of 88623249. The federal status of this trademark filing is SUSPENSION INQUIRY - MAILED as of Tuesday, September 9, 2025. This trademark is owned by Lactiga, Inc.. The LACTIGA trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Dietary supplements consisting of antibodies; Dietary supplements for general health and well-being; Dietary supplements for promoting improved antigen-specific immunity in humans; Dietary supplements for promoting improved antigen-specific immunity in animals; Protein supplements for humans; Protein supplements for animals; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes, and allergies; Pharmaceutical preparations for the treatment of infectious diseases caused by pathogens including, but not limited to, viruses, bacteria, fungi, and parasites

Proteins for use in the manufacture of dietary supplements
lactiga

General Information

Serial Number88623249
Word MarkLACTIGA
Filing DateThursday, September 19, 2019
Status651 - SUSPENSION INQUIRY - MAILED
Status DateTuesday, September 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesDietary supplements consisting of antibodies; Dietary supplements for general health and well-being; Dietary supplements for promoting improved antigen-specific immunity in humans; Dietary supplements for promoting improved antigen-specific immunity in animals; Protein supplements for humans; Protein supplements for animals; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes, and allergies; Pharmaceutical preparations for the treatment of infectious diseases caused by pathogens including, but not limited to, viruses, bacteria, fungi, and parasites
Goods and ServicesProteins for use in the manufacture of dietary supplements

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, July 2, 2020
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 2, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLactiga, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5X1E2
CA

Trademark Events

Event DateEvent Description
Wednesday, January 1, 2020NON-FINAL ACTION WRITTEN
Monday, September 23, 2019NEW APPLICATION ENTERED
Friday, September 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 19, 2019ASSIGNED TO EXAMINER
Wednesday, July 22, 2020SUSPENSION LETTER WRITTEN
Wednesday, January 1, 2020NON-FINAL ACTION E-MAILED
Wednesday, January 1, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 1, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 1, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 2, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 26, 2021SUSPENSION INQUIRY WRITTEN
Wednesday, July 22, 2020LETTER OF SUSPENSION E-MAILED
Wednesday, July 22, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, July 1, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, March 7, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 26, 2021INQUIRY TO SUSPENSION E-MAILED
Monday, July 26, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, January 13, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, January 17, 2022ASSIGNED TO LIE
Tuesday, January 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 18, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 7, 2022ASSIGNED TO EXAMINER
Monday, March 7, 2022SUSPENSION LETTER WRITTEN
Monday, March 7, 2022LETTER OF SUSPENSION E-MAILED
Friday, March 10, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, September 7, 2022SUSPENSION INQUIRY WRITTEN
Wednesday, September 7, 2022INQUIRY TO SUSPENSION E-MAILED
Wednesday, September 7, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, September 7, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, March 2, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, March 9, 2023ASSIGNED TO LIE
Thursday, March 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 10, 2023SUSPENSION LETTER WRITTEN
Friday, March 10, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, June 4, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, June 13, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, September 7, 2023SUSPENSION LETTER WRITTEN
Thursday, September 7, 2023LETTER OF SUSPENSION E-MAILED
Thursday, September 7, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, March 8, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, June 4, 2024SUSPENSION INQUIRY WRITTEN
Tuesday, June 4, 2024INQUIRY TO SUSPENSION E-MAILED
Friday, June 14, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, January 13, 2025SUSPENSION LETTER WRITTEN
Friday, June 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 14, 2024LETTER OF SUSPENSION E-MAILED
Friday, June 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 14, 2024SUSPENSION LETTER WRITTEN
Monday, July 21, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, January 13, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, January 13, 2025LETTER OF SUSPENSION E-MAILED
Tuesday, September 9, 2025SUSPENSION INQUIRY WRITTEN
Tuesday, September 9, 2025INQUIRY TO SUSPENSION E-MAILED
Tuesday, September 9, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, October 3, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, October 3, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 3, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 3, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, October 3, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

lactiga supplements dietary pharmaceutical diseases preparations animals immunity protein immunologic treatment